- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Extracapillary Glomerulonephritis in Netherlands
Total 28 results
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
University Medical Center GroningenFresenius Medical Care North AmericaCompletedAnti-glomerular Basement Membrane GlomerulonephritisNetherlands
-
Radboud University Medical CenterCompletedGlomerulonephritis, MembranousNetherlands
-
Radboud University Medical CenterHoffmann-La RocheCompleted
-
Radboud University Medical CenterDutch Kidney FoundationCompletedIdiopathic Membranous NephropathyNetherlands
-
Novartis PharmaceuticalsTerminatedGlomerulonephritis, MembranousCzechia, India, Taiwan, United Kingdom, Germany, Argentina, China, Netherlands, Spain
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Radboud University Medical CenterUnknownFocal Segmental Glomerulosclerosis | Minimal Change Disease | Idiopathic Nephrotic SyndromeNetherlands
-
GlaxoSmithKlineWithdrawnGlomerulonephritis, MembranousAustralia, Spain, United States, Canada, Germany, Netherlands, France, United Kingdom, Czech Republic, Italy
-
Novartis PharmaceuticalsCompletedIgA NephropathyColombia, Taiwan, Czechia, India, Turkey, Belgium, Netherlands, Singapore, Australia, Korea, Republic of, Thailand, Argentina, Germany, Israel, Japan, Sweden, United Kingdom, Brazil, China, Hong Kong, Norway, Finland, France, Denmark, M...
-
Medical University of ViennaMedical University of Graz; Radboud University Medical Center; Charite University... and other collaboratorsTerminatedLupus Erythematosus, Systemic | Lupus NephritisAustria, Germany, Netherlands
-
Calliditas Therapeutics ABCompletedPrimary IgA NephropathyBelgium, United Kingdom, Denmark, Finland, Sweden, Germany, Spain, Italy, Czech Republic, Netherlands
-
HI-BioCompletedTrial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (M-PLACE)Glomerulonephritis, Membranous | antiPLA2R PositiveSpain, Belgium, Australia, Italy, United States, Korea, Republic of, France, Netherlands, Poland
-
AlexionRecruitingLupus Nephritis | Immunoglobulin A NephropathyUnited States, Australia, Canada, France, Germany, Italy, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
Novartis PharmaceuticalsRecruitingPrimary IgA NephropathyJapan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
-
Novartis PharmaceuticalsActive, not recruitingIgA NephropathyUnited States, Taiwan, Czechia, Germany, Hungary, India, Turkey, Belgium, Netherlands, Singapore, Australia, Canada, Italy, Korea, Republic of, Spain, Thailand, Denmark, Slovenia, United Kingdom, Argentina, Brazil, Israel, Japan, France, Swed... and more
-
Alexion Pharmaceuticals, Inc.RecruitingImmunoglobulin A Nephropathy | IgANSpain, United Kingdom, United States, Italy, Korea, Republic of, Belgium, Germany, Colombia, Japan, China, France, Saudi Arabia, Thailand, Australia, Canada, Brazil, Malaysia, Poland, Taiwan, Austria, Greece, Israel, Netherlands, Arge... and more
-
Janssen Research & Development, LLCCompletedLupus NephritisUnited States, Belgium, Mexico, Poland, Netherlands, Thailand
-
Bristol-Myers SquibbTerminatedLupus NephritisUnited States, Taiwan, Spain, United Kingdom, Netherlands, Germany, China, Australia, Belgium, Mexico, Korea, Republic of, Czechia, Russian Federation, Israel, Canada, Italy
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedLupus NephritisUnited States, Korea, Republic of, Spain, Mexico, Philippines, Thailand, France, Germany, Belgium, Hong Kong, Taiwan, Canada, China, Argentina, United Kingdom, Brazil, Colombia, Czechia, Hungary, Netherlands, Russian Federation
-
Aurinia Pharmaceuticals Inc.CompletedLupus NephritisUnited States, Argentina, Belarus, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Croatia, Dominican Republic, Guatemala, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, North Macedonia, Peru, Philippines, Poland, Puerto Rico and more
-
Travere Therapeutics, Inc.RecruitingFocal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | Minimal Change Disease | Alport Syndrome | IgA VasculitisUnited States, Italy, Netherlands, Poland, Spain, United Kingdom, Germany, Sweden
-
River 3 Renal Corp.RecruitingFocal Segmental Glomerulosclerosis | Alport SyndromeUnited States, Belgium, United Kingdom, France, Germany, Netherlands
-
AstraZenecaRecruitingLupus NephritisChina, United States, Hungary, Germany, Italy, Belgium, India, Mexico, Vietnam, Argentina, Bulgaria, Colombia, Japan, Turkey, Taiwan, Thailand, France, Netherlands, Brazil, Malaysia, Peru, Poland, Russian Federation
-
Hansa Biopharma ABRecruitingAnti-Glomerular Basement Membrane Disease | Goodpasture Syndrome | Anti-Glomerular Basement Membrane Antibody Disease | Good Pasture SyndromeUnited States, Netherlands, Spain, Sweden, United Kingdom, Czechia, Germany, Italy, France, Denmark